Trending

Blood test that can detect breast cancer available in India now, know the cost

Meanwhile, the results of a study published in the Lancet Oncology journal showed the breast cancer patients who were given Capivasertib, developed by AstraZeneca, survived almost twice as long than those given the standard treatment alone.

Read more at www.indiatvnews.com

Show More

Related Articles

Back to top button